Centre for Policy on Ageing
 

 
Current drug treatment options in Alzheimer's disease
Author(s)Lisa Chick
Journal titleJournal of Dementia Care, vol 13, no 1, Jan/Feb 2005
Pagespp 34-35 (Research focus)
SourceEmail: shital@hawkerpublications.com
KeywordsDementia ; Drugs.
AnnotationThe author gives an overview of the medication currently licensed and recommended for the treatment of Alzheimer's disease (AD) in the UK. Aricept, Exelon and Reminyl were all approved by the National Institute for Clinical Excellence (NICE) in 2001, and should theoretically be available on prescription to anyone diagnosed with AD in England or Wales who could benefit from drug treatment. However, there is evidence that health authorities are controlling access, by limiting the number of patients who can be treated. (RH).
Accession NumberCPA-050301205 A
ClassmarkEA: LLD

Data © Centre for Policy on Ageing
...from the Ageinfo database published by Centre for Policy on Ageing.
 
CPA home >> Ageinfo Database >> Queries to: webmaster@cpa.org.uk